Terms: = Head and neck cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta
37 results:
1. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts.
Xue H; Sun Q; Zhang H; Huang H; Xue H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):156. PubMed ID: 38526631
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of ATA Low-Risk Pediatric Thyroid cancer Patients Not Treated With Radioactive Iodine Therapy.
Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
[TBL] [Abstract] [Full Text] [Related]
5. Germline Genetic Testing in Unselected Squamous and Non-Squamous head and neck cancers.
Brake DA; Idler BM; Kunze KL; Golafshar MA; Heald B; Young S; Klint M; Barrus K; Esplin ED; Nussbaum RL; Samadder NJ; Hinni ML; Chang BA
Laryngoscope; 2023 Dec; 133(12):3378-3388. PubMed ID: 37132629
[TBL] [Abstract] [Full Text] [Related]
6. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
[TBL] [Abstract] [Full Text] [Related]
7. Contrast-enhanced ultrasound (CEUS) in characterization of inconclusive cervical lymph nodes: a meta-analysis and systematic review.
Spiesecke P; Neumann K; Wakonig K; Lerchbaumer MH
Sci Rep; 2022 May; 12(1):7804. PubMed ID: 35551228
[TBL] [Abstract] [Full Text] [Related]
8. Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology.
Moscatello C; Di Marcantonio MC; Savino L; D'Amico E; Spacco G; Simeone P; Lanuti P; Muraro R; Mincione G; Cotellese R; Aceto GM
Cells; 2022 Feb; 11(5):. PubMed ID: 35269445
[TBL] [Abstract] [Full Text] [Related]
9. Forty-eight-year-old female mutyh carrier presenting with five concurrent primary cancers.
Arroyave A; Nodit L; Clegg D; Russ A
Cancer Rep (Hoboken); 2022 Feb; 5(2):e1455. PubMed ID: 34173730
[TBL] [Abstract] [Full Text] [Related]
10. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract] [Full Text] [Related]
11. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid cancer Patients on Tyrosine Kinase Inhibitor Therapy.
Tomoda C; Sugino K; Kitagawa W; Nagahama M; Ito K
ORL J Otorhinolaryngol Relat Spec; 2021; 83(5):347-353. PubMed ID: 33735904
[TBL] [Abstract] [Full Text] [Related]
12. Do Molecular Profiles of Primary
Gomes-Lima CJ; Shobab L; Wu D; Ylli D; Bikas A; McCoy M; Feldman R; Lee W; Rao SN; Jensen K; Vasko V; Castro LC; Jonklaas J; Wartofsky L; Burman KD
Front Endocrinol (Lausanne); 2021; 12():623182. PubMed ID: 33716974
[TBL] [Abstract] [Full Text] [Related]
13. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract] [Full Text] [Related]
14. A case report of a patient with first phenotype of papillary thyroid carcinoma and heterochronous multiprimary tumor harboring germline mutyh Arg19*/Gly286Glu mutations.
Wang M; Zhu F; Luo N; Han T; Wang M
Oral Oncol; 2021 Jan; 112():104987. PubMed ID: 32888815
[TBL] [Abstract] [Full Text] [Related]
15. Predictive value of genetic variants XRCC1 rs1799782, APEX1 rs1760944, and mutyh rs3219489 for adjuvant concurrent chemoradiotherapy outcomes in oral squamous cell carcinoma patients.
Senghore T; Chien HT; Wang WC; Chen YX; Young CK; Huang SF; Yeh CC
Pharmacogenomics J; 2020 Dec; 20(6):813-822. PubMed ID: 32461665
[TBL] [Abstract] [Full Text] [Related]
16. Increased prevalence of Barrett's esophagus in patients with mutyh-associated polyposis (MAP).
Daans CG; Ghorbanoghli Z; Velthuizen ME; Vasen HFA; Offerhaus GJA; Lacle MM; Siersema PD; Ausems MGEM; Boonstra JJ
Fam Cancer; 2020 Apr; 19(2):183-187. PubMed ID: 32088803
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
[TBL] [Abstract] [Full Text] [Related]
18. Downregulation of mutyh contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMT.
Guo Y; Jia Y; Wang S; Liu N; Gao D; Zhang L; Lin Z; Wang S; Kong F; Peng C; Liu Y
Oncol Rep; 2019 Dec; 42(6):2716-2727. PubMed ID: 31578574
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of APC and mutyh mutations to familial adenomatous polyposis susceptibility in Hungary.
Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
[TBL] [Abstract] [Full Text] [Related]
20. SIRT6 protein deacetylase interacts with myh DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp.
Hwang BJ; Jin J; Gao Y; Shi G; Madabushi A; Yan A; Guan X; Zalzman M; Nakajima S; Lan L; Lu AL
BMC Mol Biol; 2015 Jun; 16():12. PubMed ID: 26063178
[TBL] [Abstract] [Full Text] [Related]
[Next]
